DSCSA for Manufacturers

See how global pharmaceuticals company Noden Pharma avoided the financial and operational risks of DSCSA noncompliance.

See how Sharp Packaging Services overcame EPCIS change management challenges in the pharma supply chain with TraceLink's help.

See how TraceLink's powerful digital supply network enables customers to quickly connect to trade partners for scaling up business process ecosystems.

TraceLink's breakthrough blockchain solution, Trace Histories, can help pharma customers comply with US DSCSA regulations that go into effect in 2023.

TraceLink helps customers meet DSCSA saleable returns verification requirements via the Verification Router Service model. See how.

See how Value Drug Company standardized the process for illegitimate and suspect product investigations for DSCSA compliance.

The mission of U.S. contract packager Sharp Packaging is to drive the convergence between the physical package and the digital data points as they…

Insights into the November 27, 2017, FDA draft guidance around grandfathering product under DSCSA.

In May 2018, the FDA published new DSCSA guidance.

Understand what the announcement means for pharma companies as the November 2017 deadline approaches.

Hear Sharp technical executives discuss the similarities and the critical differences between U.S. DSCSA and EU FMD.

Learn the criteria for choosing a VRS as the foundation of a saleable returns solution, including network governance, scalability, and…